Eco R1 Capital, LLC Neoleukin Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.72 - $5.23 $1.48 Million - $4.5 Million	-860,619 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $9.06 Million - $14.5 Million	-1,498,185 Reduced 63.51%	860,619 $6.22 Million
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $7.05 Million - $10 Million	-763,900 Reduced 24.46%	2,358,804 $21.8 Million
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $7.53 Million - $10.8 Million	-740,227 Reduced 19.16%	3,122,704 $44 Million
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $3.16 Million - $5.55 Million	326,247 Added 9.22%	3,862,931 $46.4 Million
Q2 2020 Aug 14, 2020	SELL	$9.95 - $17.05 $1.56 Million - $2.67 Million	-156,519 Reduced 4.24%	3,536,684 $58.7 Million
Q1 2020 May 15, 2020	SELL	$6.12 - $13.64 $1.36 Million - $3.04 Million	-222,677 Reduced 5.69%	3,693,203 $42 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $4.37 Million - $21 Million	1,650,000 Added 72.82%	3,915,880 $48.2 Million
Q3 2019 Nov 14, 2019	BUY	$2.33 - $3.76 $5.28 Million - $8.52 Million	2,265,880 New	2,265,880 $6.46 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.